Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine

Int J Antimicrob Agents. 2011 Jan;37(1):58-61. doi: 10.1016/j.ijantimicag.2010.08.008. Epub 2010 Oct 14.


Using a murine model of disseminated infection by Fusarium verticillioides, the efficacy of liposomal amphotericin (L-AmB) B at 10mg/kg body weight once daily and terbinafine (TRB) at 150 mg/kg body weight twice daily, alone and in combination, was evaluated. The combination of L-AmB with TRB was the only treatment able to prolong survival and to reduce fungal loads in the spleen and kidneys of mice infected with either strain of F. verticillioides used. The results suggest that this combination may have a role in the treatment of F. verticillioides infection.

MeSH terms

  • Amphotericin B / administration & dosage*
  • Animals
  • Antifungal Agents / therapeutic use*
  • Colony Count, Microbial
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Fusarium / drug effects*
  • Fusarium / isolation & purification
  • Kidney / microbiology
  • Male
  • Mice
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Naphthalenes / administration & dosage*
  • Spleen / microbiology
  • Survival Analysis
  • Terbinafine
  • Treatment Outcome


  • Antifungal Agents
  • Naphthalenes
  • liposomal amphotericin B
  • Amphotericin B
  • Terbinafine